Henry Brem
Direttore/Membro del Consiglio presso LikeMinds, Inc. (Massachusetts)
Profilo
Henry Brem is the founder of Focal, Inc. He currently holds director positions at Galen Robotics, Inc., LikeMinds, Inc. (Massachusetts), Cranius LLC, and is a venture partner at Catalio Capital Management LP.
Previously, he was a director at Alseres Pharmaceuticals, Inc. from 2007 to 2010.
He also held a director position in Maryland.
Brem received his doctorate from Harvard University in 1978 and his undergraduate degree from New York University in 1973.
Posizioni attive di Henry Brem
Società | Posizione | Inizio |
---|---|---|
LikeMinds, Inc. (Massachusetts)
LikeMinds, Inc. (Massachusetts) Personnel ServicesCommercial Services LikeMinds, Inc. intends to make brain imaging part of the standard suite of healthcare diagnostic tests and technologies. The company was founded in 2018 and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | - |
Galen Robotics, Inc.
Galen Robotics, Inc. Medical DistributorsDistribution Services Galen Robotics, Inc. is a startup company that is developing the Galen platform to democratize robotic surgery, surgical robots, digital surgery, and minimally invasive surgery. Galen Robotics is based in Baltimore, MD. The company aims to expand the benefits of microsurgery and surgical robotics by enabling precise surgical maneuvers. The company was founded by Dave Saunders and Bruce Lichorowic, with Bruce Lichorowic serving as the CEO since incorporation. | Direttore/Membro del Consiglio | - |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Investitore di Private Equity | - |
Cranius LLC
Cranius LLC Medical SpecialtiesHealth Technology Cranius LLC is a company based in Maryland that aims to invent and engineer technology to define the future of diagnostics and treatments for patients with chronic brain disease. The American company's flagship device, the Neuropass, is being developed to bypass the challenges presented by the blood-brain barrier, which has rendered traditional therapeutic treatments of brain disease ineffective. Cranius utilizes a novel pump design, refillable reservoir, MRI-lucent components, and wireless charging technology to enable long-term and direct medicine administration. The company was founded in May 2021 as a byproduct of the emerging field known as "neuroplastic and reconstructive surgery," through the vision, insight, and pioneering work of Dr. Chad Gordon. The CEO is Mike Maglin. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Henry Brem
Società | Posizione | Fine |
---|---|---|
ALSERES PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 08/01/2010 |
Focal, Inc.
Focal, Inc. Chemicals: SpecialtyProcess Industries Focal Inc, is a developing biodegradable interventional therapeutic products to treat serious local diseases. The company products consist of a biodegradable polymer system that can deliver drugs locally to the site of disease and/or act as a physical barrier. Other Focal research & development programs include polymer and drug delivery products to: prevent adhesions (internal scar tissue) following surgery; serve as surgical sealants; and deliver drugs locally for other indications. | Fondatore | - |
Maryland / Israel Development Center
Maryland / Israel Development Center Miscellaneous Commercial ServicesCommercial Services Maryland / Israel Development Center operates as a non-profit membership organization. It promotes bi-lateral trade and investment between Maryland and Israeli companies. The company is headquartered in Baltimore, MD. | Direttore/Membro del Consiglio | - |
Formazione di Henry Brem
Harvard University | Doctorate Degree |
New York University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ALSERES PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 6 |
---|---|
Focal, Inc.
Focal, Inc. Chemicals: SpecialtyProcess Industries Focal Inc, is a developing biodegradable interventional therapeutic products to treat serious local diseases. The company products consist of a biodegradable polymer system that can deliver drugs locally to the site of disease and/or act as a physical barrier. Other Focal research & development programs include polymer and drug delivery products to: prevent adhesions (internal scar tissue) following surgery; serve as surgical sealants; and deliver drugs locally for other indications. | Process Industries |
Maryland / Israel Development Center
Maryland / Israel Development Center Miscellaneous Commercial ServicesCommercial Services Maryland / Israel Development Center operates as a non-profit membership organization. It promotes bi-lateral trade and investment between Maryland and Israeli companies. The company is headquartered in Baltimore, MD. | Commercial Services |
Galen Robotics, Inc.
Galen Robotics, Inc. Medical DistributorsDistribution Services Galen Robotics, Inc. is a startup company that is developing the Galen platform to democratize robotic surgery, surgical robots, digital surgery, and minimally invasive surgery. Galen Robotics is based in Baltimore, MD. The company aims to expand the benefits of microsurgery and surgical robotics by enabling precise surgical maneuvers. The company was founded by Dave Saunders and Bruce Lichorowic, with Bruce Lichorowic serving as the CEO since incorporation. | Distribution Services |
LikeMinds, Inc. (Massachusetts)
LikeMinds, Inc. (Massachusetts) Personnel ServicesCommercial Services LikeMinds, Inc. intends to make brain imaging part of the standard suite of healthcare diagnostic tests and technologies. The company was founded in 2018 and is headquartered in Boston, MA. | Commercial Services |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
Cranius LLC
Cranius LLC Medical SpecialtiesHealth Technology Cranius LLC is a company based in Maryland that aims to invent and engineer technology to define the future of diagnostics and treatments for patients with chronic brain disease. The American company's flagship device, the Neuropass, is being developed to bypass the challenges presented by the blood-brain barrier, which has rendered traditional therapeutic treatments of brain disease ineffective. Cranius utilizes a novel pump design, refillable reservoir, MRI-lucent components, and wireless charging technology to enable long-term and direct medicine administration. The company was founded in May 2021 as a byproduct of the emerging field known as "neuroplastic and reconstructive surgery," through the vision, insight, and pioneering work of Dr. Chad Gordon. The CEO is Mike Maglin. | Health Technology |
- Borsa valori
- Insiders
- Henry Brem